Page last updated: 2024-09-04

pomalidomide and phenformin

pomalidomide has been researched along with phenformin in 1 studies

Compound Research Comparison

Studies (pomalidomide)	Trials (pomalidomide)	Recent Studies (post-2010) (pomalidomide)	Studies (phenformin)	Trials (phenformin)	Recent Studies (post-2010) (phenformin)
623	121	552	1,550	130	163

Protein Interaction Comparison

Protein	Taxonomy	pomalidomide (IC50)	phenformin (IC50)
Solute carrier family 22 member 1	Homo sapiens (human)		10

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dingli, D; Mishra, AK	1

Other Studies

1 other study(ies) available for pomalidomide and phenformin

Article	Year
Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells. Leukemia, 2019, Volume: 33, Issue:11 Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Bortezomib; Cell Line, Tumor; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Interleukin-6; Metformin; Multiple Myeloma; Phenformin; Plasma Cells; Receptors, Interleukin-6; Sequence Analysis, RNA; Signal Transduction; Syndecan-1; Thalidomide	2019

Article

Year

Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells.

Leukemia, 2019, Volume: 33, Issue:11

Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Bortezomib; Cell Line, Tumor; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Interleukin-6; Metformin; Multiple Myeloma; Phenformin; Plasma Cells; Receptors, Interleukin-6; Sequence Analysis, RNA; Signal Transduction; Syndecan-1; Thalidomide

2019